Megan Farmer
Acute Care · Dalton, GANPI 1689159261
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,578 of the $3,056 with a category attached, or 84.4%. 25 manufacturers reported payments, led by Medtronic at 34.1% of the total. 2025 is the largest year on record at $1,607, more than ten times the $12 reported in 2021. Among acute care clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $29.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Novartis$536
- E.r. Squibb & Sons, L.L.C.$209
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$181
- Pfizer$164
- AstraZeneca$161
- plus $763 from 19 others
What the payments were for
- Travel & lodging$46915%
- Food & beverage$2,57884%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 11 | $1,042 |
| Novartis | 21 | $536 |
| E.r. Squibb & Sons, L.L.C. | 12 | $209 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $181 |
| Pfizer | 8 | $164 |
| AstraZeneca | 9 | $161 |
| Kestra Medical Technology Services, Inc. | 6 | $142 |
| Actelion Pharmaceuticals US, Inc. | 4 | $72 |
| Boston Scientific | 2 | $68 |
| Boehringer Ingelheim | 4 | $63 |
| Amgen | 3 | $46 |
| Novo Nordisk | 2 | $40 |
| Philips North America LLC | 1 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $35 |
| Abbott | 1 | $33 |
| Cvrx, Inc. | 1 | $31 |
| United Therapeutics Corporation | 1 | $28 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| Vital Connect, Inc | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Bridgebio Pharma, Inc. | 1 | $17 |
| Merck | 1 | $17 |
| Heartflow, Inc. | 1 | $17 |
| Bayer | 1 | $15 |
How this compares
$3,056 in reported general payments places this provider in the 90th percentile of 679 acute care providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in Dalton
- Amber McMahanDalton$8K
- Lindsey KiddDalton$4K
- Darryl TurnerRinggold$21K
- Bryce CowgillCumming$16K
- Stacy CreelSavannah$15K
- Susan BeitzellAthens$13K
- Crystal KuhnCumming$12K
- Mark ClarkGainesville$10K
- Sarah WymanAtlanta$10K
- Jeffrey DillerAustell$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.